Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A.

Abstract

To establish the pharmacokinetic profile of activated recombinant coagulation factor VII (rFVIIa; NovoSeven in children with haemophilia A, and to compare it with the pharmacokinetic profile in adults with haemophilia A. Twelve children (2-12 years) received one single dose of rFVIIa 90 and 180 micrograms kg(-1) in randomized order separated by a washout period of 48 h to 1 month. Six adults (18-55 years) received a single dose of rFVIIa 90 micrograms kg(-1). The pharmacokinetic analyses were based on a non-compartmental method. In children, the plasma level of FVII increased proportionally with the dose. The total body clearance normalized for body weight was significantly faster in children than in adults (FVII:C, 58 vs. 39 mL kg(-1) h(-1) and FVIIa, 78 vs. 53 mL kg(-1) h(-1), P < 0.05). A trend towards a larger volume of distribution at steady-state in children than in adults was observed (P > 0.05). Dose proportionality was established for plasma concentrations of FVII in children with haemophilia A at the dose levels investigated (90 and 180 micrograms kg(-1) rFVIIa). Following administration of rFVIIa 90 micrograms kg(-1), significantly faster clearance was observed in children compared with adults, suggesting that higher doses of rFVIIa may be needed to achieve the same plasma levels as in adults.

• Authors: A Villar, S Aronis, M Morfini, E Santagostino, G Auerswald, H F Thomsen, E Erhardtsen, P L F Giangrande
• Journal: Haemophilia : the official journal of the World Federation of Hemophilia (Haemophilia) Vol. 10 Issue 4 Pg. 352-9 (Jul 2004) ISSN: 1351-8216 [Print] England
• PMID: 15230949 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial)

Chemical References

• Recombinant Proteins
• Factor VII
• recombinant FVIIa
• Factor VIIa

Topics

• Child
• Child, Preschool
• Factor VII (analysis, pharmacokinetics)
• Factor VIIa (analysis)
• Half-Life
• Hemophilia A (metabolism)
• Humans
• Injections, Intravenous
• Plasma (chemistry)
• Recombinant Proteins (pharmacokinetics)